TABLE 1.
Name of assay | Principle | Company | Target gene | Sensitivity | Time (min) | References |
RT-LAMP assay | RT-LAMP | — | N | 100 copies/rxn | 30 | Baek et al., 2020 |
mRT-LAMP-LFB | RT-LAMP | — | ORF1ab, N | 12 copies/rxn | 40 | Zhu et al., 2020 |
COVID-19-LAMP | RT-LAMP | — | ORF3a, E | 42 copies/rxn | 60 | Chow et al., 2020 |
Suitcase lab | RT-RPA | — | E, N | 15 copies/rxn | 15 | El Wahed et al., 2021 |
— | RT-RPA | — | N | 8 copies/rxn | 20 | Behrmann et al., 2020 |
Respiratory Virus Nucleic Acid Detection Kit | RT-LAMP | CapitalBio Technology | ORF1ab, N | 150 copies/ml | 90 | CapitalBio coporation, 2022 |
Novel Coronavirus (2019-nCoV) Nucleic Acid Detection Kit | CPA | Ustar Biotechnologies | ORF1ab, N | 200 copies/ml | 80 | USTAR, 2022 |
iAMP COVID-19 Detection Kit | RT-LAMP | Atila BioSystems | ORF1ab, N | 4 copies/μl | <90 | Rai et al., 2021 |
ID NOW COVID-19 | NEAR | Abbott Diagnostics Scarborough | RdRp | 125 copies/ml | 15 | Abbott Diagnostics, 2020 |
SHERLOCK CRISPR SARS-CoV-2 Kit | RT-LAMP, CRISPR-Cas13 | Sherlock Biosciences | ORF1ab, N | 4.5 copies/μl–ORF1ab; 0.9 copies/μl–N | 60 | Sherlock Biosciences, 2021 |
SARS-CoV-2 DETECTR Reagent Kit | RT-LAMP, CRISPR-Cas12 | Mammoth Biosciences | E, N | 10 copies/μl | 45 | Broughton et al., 2020 |
CPA, cross priming amplification; NEAR, nicking enzyme amplification reaction.